PATENT CLAIM ANALYSIS

Application Number: 16069092
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["424", "450000"]

Abstract:
Novel compounds inhibiting ATR protein kinase include compounds of formula (I) disclosed herein, as well as liposome formulations comprising ATR protein kinase inhibitor compounds. The compositions are useful for the treatment of cancer.

Claim (Index 15):
The liposome composition of  claim 4 , wherein the ATR protein kinase inhibitor compound is Compound 1.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.26667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15337274', '15852551', '15027997', '15241128', '13662135']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6283952696073348
- 35 USC 102 Novelty (BERT): 0.5243674244025287
- Combined Prediction Score: 0.6179924850868542
- Mean Citation Score: 255.986702
- Max Citation Score: 285.9236
- Similarity Product: 188.26769176735883

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test